Henke-Gendo C, Harste G, Juergens-Saathoff B, Mattner F, Deppe H, Heim A
Institute of Virology, Medical School Hannover, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany.
J Clin Microbiol. 2009 Sep;47(9):2855-62. doi: 10.1128/JCM.00448-09. Epub 2009 Jul 22.
Noroviruses (NoV) are a major cause of epidemic nonbacterial gastroenteritis and affect all age groups worldwide. Three of five NoV genogroups, namely, genogroup I (GI), GII, and GIV, are associated with human disease. Unfortunately, these genogroups demonstrate a high degree of sequence diversity, complicating the design of pan-NoV diagnostic PCR tests. To decrease the risk of false-negative test results, we have developed a new one-step real-time TaqMan reverse transcription-PCR protocol. This protocol detects all human NoV genogroups in one reaction with a sensitivity of 400 virus genome equivalents/reaction for both GI and GII. The use of in vitro-transcribed NoV RNA as an external standard allows (semi)quantification of viral loads in samples. In a retrospective analysis of 206 stool samples from 77 patient episodes, the duration of NoV excretion and the amount of virus excreted were determined. Twenty (26.0%) of these episodes lasted longer than 10 days. Univariate risk factor analysis revealed the patient status after organ transplantation (odds ratio [OR], 7.49 [95% confidence interval, 2.06 to 28.32]; P < 0.001), immunosuppression (OR, 9.19 [95% confidence interval, 2.50 to 35.39]; P < 0.001), and age of less than 10 years (OR, 4.58 [95% confidence interval, 1.36 to 15.77]; P = 0.004) as risk factors for a NoV excretion period of more than 10 days. These findings were confirmed by time-dependent Kaplan-Meier analyses, whereas multivariate Cox regression analyses identified immunosuppression as the sole risk factor. Surprisingly, in contrast to the excretion periods, the viral loads in stools did not increase in connection with age or immunosuppressive status. This fact may be one important piece in the pattern of high-level NoV transmissibility and may have an impact on the development of transmission prevention strategies.
诺如病毒(NoV)是流行性非细菌性肠胃炎的主要病因,影响着全球所有年龄组。五个诺如病毒基因组中的三个,即基因组I(GI)、GII和GIV,与人类疾病相关。不幸的是,这些基因组表现出高度的序列多样性,使得通用诺如病毒诊断性PCR检测的设计变得复杂。为降低假阴性检测结果的风险,我们开发了一种新的一步法实时TaqMan逆转录PCR方案。该方案可在一次反应中检测所有人类诺如病毒基因组,对GI和GII的灵敏度均为400个病毒基因组当量/反应。使用体外转录的诺如病毒RNA作为外部标准可对样品中的病毒载量进行(半)定量。在对77例患者的206份粪便样本进行的回顾性分析中,确定了诺如病毒排泄的持续时间和排出的病毒量。其中20例(26.0%)病程持续超过10天。单因素风险因素分析显示,器官移植后的患者状态(比值比[OR],7.49[95%置信区间,2.06至28.32];P<0.001)、免疫抑制(OR,9.19[95%置信区间,2.50至35.39];P<0.001)以及年龄小于10岁(OR,4.58[95%置信区间,1.36至15.77];P = 0.004)是诺如病毒排泄期超过10天的风险因素。这些发现通过时间依赖性Kaplan-Meier分析得到证实,而多变量Cox回归分析确定免疫抑制是唯一的风险因素。令人惊讶的是,与排泄期不同,粪便中的病毒载量并未随着年龄或免疫抑制状态的增加而升高。这一事实可能是诺如病毒高传播性模式中的一个重要因素,可能会对传播预防策略的制定产生影响。